Medtech Insight and Windhover Information's 'Investment In Innovation' Medical Technology Investment Conference to Feature Interactive Panel Discussing the Relationship Between VCs and Entrepreneurs.NEWPORT BEACH Newport Beach, residential and resort city (1990 pop. 66,643), Orange co., S Calif., on Newport Bay and the Pacific Ocean; inc. 1906. It is a popular seaside resort and yachting center. Manufactures include electrical and medical equipment, computers, boats, and adhesives. , Calif. -- "Investment In Innovation (In3): A Preview of Early-Stage Medical Technology Companies"; Oct. 21-22, 2004, The Westin Copley Place Copley Place is an enclosed shopping mall located in the Back Bay section of Boston, Massachusetts. It is part of a complex that includes office buildings, two hotels, and a parking garage. Hotel, Boston Medtech Insight, a division of Windhover wind·hov·er n. Chiefly British A kestrel. Information and a leading provider of business information on new trends, technologies and emerging companies in the medical device industry, has announced that its upcoming "Investment In Innovation (In3): A Preview of Early-Stage Medical Technology Companies" conference, to be held Oct. 21-22, 2004, at The Westin Copley Place Hotel in Boston, will feature a dynamic, interactive panel discussion titled "Seeing Eye to Eye: The Relationship between VCs and Entrepreneurs." The session will be moderated by David Cassak, managing partner at Windhover Information, a healthcare market expert with over 20 years of industry experience. Panelists participating in the Friday afternoon, Oct. 22 discussion will include a number of leading venture capitalists and serial entrepreneurs, such as Rob Andrews Robert Ernest "Rob" Andrews (born August 4, 1957) is an American Democratic Party politician from New Jersey, who is currently serving as a member of the U.S. House of Representatives, representing New Jersey's At-large congressional district (map). , director of Healthcare Investment Banking at Houlihan Lokey Howard & Zukin, and Kenneth L. Cutler, partner and co-chair, Emerging Companies, at Dorsey & Whitney LLP LLP - Lower Layer Protocol , among others to be announced To be announced (TBA) A contract for the purchase or sale of an MBS to be delivered at an agreed-upon future date but does not include a specified pool number and number of pools or precise amount to be delivered. . The In3 Boston conference will also feature presentations from approximately 60 emerging medical technology companies seeking funding, acquisition, and/or strategic partnership opportunities. Presenting companies will represent a diverse range of major medical device sectors including cardiovascular and neurovascular disease, spine/orthopedics, imaging and surgical navigation technology, critical care, oncology, drug delivery, women's health Women's Health Definition Women's health is the effect of gender on disease and health that encompasses a broad range of biological and psychosocial issues. and oncology, among others. Companies confirmed thus far to present at the Boston event include: Access Bio, Access CardioSystems, Acologix, Acta Vascular Systems, Adiana, Advanced Bioelectric bi·o·e·lec·tric also bi·o·e·lec·tri·cal adj. 1. Of or having to do with the electric current generated by living tissue. 2. Of or relating to the effects of electricity on living tissue. , Advanced Medical Diagnostics, Affinergy, Applied Spine Technologies, Argentum Medical, Audiomedix, BioCare Systems, BioniCare Medical Technologies, Biowave, Bone Solutions, Cardiac Assist, Cardio-Optics, Cerdak, Chiroxia, Clinicon, Cordeus, CoreValve, Endomed, GARRETTtechnologies, Gene Express, GlucoLight, Haptica, Hayes Medical, Heart Assist Technologies, HemaMetrics, Intelligent Medical Devices, Keimar, LifeAssays, LumeRx, Mazor Surgical Technologies, MDMI MDMI Monodisperse Dried Microparticulate Injector MDMI Matthew David Miller Investments (Milton, MA) Technologies, MicroMRI, MINRAD, MiTiHeart, Monteris Medical, Nanolution, Nervonix, NMT (Nordic Mobile Telephone) An analog cellular phone system deployed in more than 40 countries in Europe. Launched in the Scandinavian countries in 1979, NMT was the first analog cellphone system. Both 450 MHz and 900 MHz versions are available. See cellular generations. Medical, NovoSci, NsGene, OMRIX biopharmaceuticals, Os Technology, OsteoResorb, Percardia, Polymerix, Proxy Biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. , SafetyNet, SmokeSignals, Stheno, Triton BioSystems, Utopix, Valor valor a rodenticide no longer marketed because of toxicity in horses causing dehydration, abdominal pain, hindlimb weakness, inappetence, fishy smell in urine. Called also N-3-pyridyl methyl N1-p-nitrophenyl urea. Medical, Viking Systems, and ZARS (see www.medtechinsight.com for an updated listing and descriptions of each company's technology). The conference will be attended by approximately 400 senior executives from most of the leading healthcare investment firms and medical device companies. See the Medtech Insight Web site at http://www.medtechinsight.com/in3-12.html for conference details and registration information. The Boston conference will be kicked off by a keynote presentation by industry veteran Rick Randall, whose medical device industry experience includes positions as president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Target Therapeutics, Incumed, Innovasive Devices, and Conceptus conceptus /con·cep·tus/ (-tus) the product of the union of oocyte and spermatozoon at any stage of development from fertilization until birth, including extraembryonic membranes as well as the embryo or fetus. . Randall is currently president and CEO of TranS1, a development-stage, minimally invasive spine surgery company. Featured speakers include Kevin Collins, partner, and Janet MacLeod, Ph.D., associate, at Dorsey & Whitney LLP, speaking to meeting participants about "Setting Up Your Company for Successful Acquisition," and James M. Garvey, managing partner and CEO of Schroder Ventures Life Sciences, who will discuss "The State of Healthcare Investing in 2004 and Beyond." In addition, Harvey Rudolph, Ph.D., Global Medical Program manager at Underwriters Laboratories, will add his insights in a presentation titled "Why Do I Have To Do Risk Management?" Rounding out the Boston program will be an informative panel discussion organized by the investment banking firm Houlihan Lokey Howard & Zukin titled "Valuation Methodologies for Early- and Late-Stage Medical Technology Companies." Panelists for this discussion include Rob Andrews, director of Healthcare Investment Banking, Gary Brewster, senior vice president, and Naomi Derner, vice president, at Houlihan Lokey Howard & Zukin. In3 Boston is a must-attend event for anyone interested in emerging medical technology companies. To register, call Medtech Insight at 949-219-0150, or 888-290-2225 toll-free in the United States, or register on the Medtech Insight Web site at http://www.medtechinsight.com/in3-12.html. To read what industry experts think of Medtech Insight's conferences, please visit http://www.medtechinsight.com/in3success.html. ABOUT MEDTECH INSIGHT Recently acquired by Windhover Information Inc., publisher of IN VIVO in vivo /in vi·vo/ (ve´vo) [L.] within the living body. in vi·vo adj. Within a living organism. in vivo adv. : The Business & Medicine Report, and Start-UP: Windhover's Review of Emerging Technologies, Medtech Insight is a leading provider of business information for the medical technology marketplace. The company publishes the "medtech insight" newsletter, a monthly publication covering the latest trends and innovations in the medical technology industry. The company also publishes analyses of medtech markets through its Market & Technology Reports group, offers custom consulting and market research, and holds medical technology investment conferences several times a year. To register for the Boston conference or for more information on the company's upcoming "IN SPINE: Strategic Partnering and Investing in Spine" conference, being held in Dallas on Nov. 11, 2004, please call 949-219-0150 or 888-290-2225 toll-free in the United States, fax 949-219-0067, e-mail in3@medtechinsight.com, or visit www.medtechinsight.com. Visit the company's Web site to read more about the company's upcoming conferences, view tables of contents for published and upcoming reports, and download a sample issue of the "medtech insight" newsletter. Windhover Information Inc. (http://www.windhover.com/), based in Norwalk, Conn., is a leading provider of information products and services to senior executives in the pharmaceutical, biotechnology, and medical device industries. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion